- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00732355
Syph-Check Syphilis Antibody Point of Care (POC) Test (SyphPoc)
February 29, 2016 updated by: Healthcare Providers Direct, Inc.
One-Step Syphilis Point of Care Test for Rapid Immunoassay Screening of Antibodies to Treponema Pallidum
The study is designed to evaluate the performance of a rapid membrane test in a clinic or doctor's office setting to identify potential patients infected with syphilis and compare the results to currently licensed laboratory based tests.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
The overall objectives of this study are to determine the performance characteristics of a candidate rapid point-of-care test (Syph-Check cassette format) for Treponema pallidum antibodies in serum, plasma and finger stick whole blood obtained from females and males attending sexually transmitted diseases (STD) clinics, family planning / reproductive health clinics, and physician's office; and to compare the performance of this new, rapid test to currently licensed laboratory based tests, the non-treponemal RPR and a Treponemal ELISA or TPPA test.
Study Type
Observational
Enrollment (Actual)
400
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21205
- Johns Hopkins University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Point of Care clinics and doctor's office that test routine patients (both male and female), i.e.
STD clinics, planned parenthood, pre-marital, blood donors, pre-employment, and general populations from different geographic locations having varying prevalence populations.
Description
Inclusion Criteria:
Men and Women will be eligible who:
- are 18 years of age or older;
- Routine "presumed uninfected" for screening visit, or show symptomatic signs of infection or are asymptomatic but are suspected of infection, and either/or have other STD disease conditions and infections, will be identified.
- Pregnant women in the first and third trimester
Exclusion Criteria:
- are under 18 years of age
- unwillingness to give consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
I
known syphilis infected patients
|
Rapid membrane test for syphilis antibodies
Other Names:
|
U
presumed uninfected patients
|
Rapid membrane test for syphilis antibodies
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Identify the sensitivity and specificity of the POC test versus accepted laboratory tests
Time Frame: end of study
|
end of study
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Percent positive agreement data will include supplemental test results identified by infection categories and treatment as possible
Time Frame: end of study
|
end of study
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Gary L Lehnus, Ph.D., Lehnus & Associates Consulting
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2009
Primary Completion (ACTUAL)
February 1, 2010
Study Completion (ACTUAL)
September 1, 2010
Study Registration Dates
First Submitted
August 8, 2008
First Submitted That Met QC Criteria
August 11, 2008
First Posted (ESTIMATE)
August 12, 2008
Study Record Updates
Last Update Posted (ESTIMATE)
March 2, 2016
Last Update Submitted That Met QC Criteria
February 29, 2016
Last Verified
February 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SY-101
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Screening for Syphilis Infections
-
Unity Health TorontoCanadian Institutes of Health Research (CIHR); University of TorontoCompletedScreening for Partner ViolenceCanada
-
GI View Ltd.Terminated
-
Centre Hospitalier Intercommunal CreteilNot yet recruitingthe Rate of Participation in Screening for PBC
-
Cairo UniversityRecruitingOral Screening for Elderly in Aged Care HomesEgypt
-
Ottawa Hospital Research InstituteCIHR Canadian HIV Trials NetworkTerminatedSyphilis | Primary Syphilis | Secondary Syphilis | Early-Latent SyphilisCanada
-
NovartisCompletedScreening for the Presence of HIV-1, RNA and HBV DNA in Blood DonationsTaiwan
-
Fundación FLS de Lucha Contra el Sida, las Enfermedades...RecruitingPrimary Syphilis | Secondary Syphilis | Early Latent SyphilisSpain, United Kingdom
-
Artann LaboratoriesNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University... and other collaboratorsCompletedOutpatient Colonoscopy for Colorectal Cancer Screening or for Symptoms Suggestive of Colonic DiseasesUnited States
-
AeskuLab Pathology PragueInstitute of Biostatistics and analyses, Ltd.CompletedAlgorithm for Cervix Carcinoma ScreeningCzechia
-
Hospital de Niños R. Gutierrez de Buenos AiresCompleted
Clinical Trials on Syph-Check POC
-
Stanford UniversitySanta Clara Valley Medical CenterWithdrawnCongenital Syphilis | Maternal Syphilis During Pregnancy - Baby Not Yet DeliveredUnited States
-
ResMedCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Helsinki University Central HospitalCompleted
-
Firalis SAIstanbul UniversityRecruiting
-
Walter Reed Army Institute of Research (WRAIR)Recruiting
-
Elizabeth Glaser Pediatric AIDS FoundationUNITAIDCompletedHIV Infections | HIV/AIDS | Infant Morbidity | Perinatal HIV InfectionZimbabwe
-
Queen's University, BelfastInnovate UK; Northern Ireland Clinical Trials UnitActive, not recruitingAcute Respiratory Distress Syndrome (ARDS)United Kingdom, Ireland
-
Clinton Health Access Initiative Inc.UNICEF; Ministry of Health, MalawiCompleted
-
Soroka University Medical CenterUnknownCentral Venous CatheterIsrael
-
University of CatanzaroAzienda Sanitaria Provinciale Di Catanzaro; Azienda Ospedaliera Universitaria...Recruiting